4//SEC Filing
Ehrlich Christopher B 4
Accession 0001209191-24-003702
CIK 0001828522other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:25 PM ET
Size
5.6 KB
Accession
0001209191-24-003702
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-02-19+2,000→ 2,000 totalExercise: $11.32Exp: 2034-02-18→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in substantially equal monthly installments over 12 months, commencing on February 19, 2024, subject to the Reporting Person's continued service with the Issuer through each vesting date.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001293973
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 5:25 PM ET
- Size
- 5.6 KB